Upcoming Investor Events and Conferences

Summary by AI BETAClose X

Oxford Nanopore Technologies plc announced its participation in two upcoming investor conferences in January 2026. The company will present and hold Q&A sessions at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 12th, with a webcast available, and will engage in one-on-one and group investor meetings at the dbAccess UK & Ireland Conference in London on January 20th.

Disclaimer*

Oxford Nanopore Technologies plc
07 January 2026
 

Oxford Nanopore Technologies plc

("Oxford Nanopore" or the "Company")

Oxford Nanopore to participate in upcoming investor conferences

07 January 2026

 

Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of molecular sensing technology based on nanopores, will be participating in the following investor conferences in January.

 

·      44th Annual J.P. Morgan Healthcare Conference, San Francisco

Format: Presentation and Q&A session and investor meetings

Date: Monday, 12 January

Time: 2:15pm PT (5:15pm EST/10:15pm GMT)

Webcast: click here to register

 

·      dbAccess UK & Ireland Conference, London

Format: One-on-one and group investor meetings

Date: Tuesday, 20 January

 

A live webcast of the J.P. Morgan presentation and Q&A can be accessed at the Company's investor relations page at: https://nanoporetech.com/about/investors/reports. A webcast replay will be available for at least 30 days following the event via the same link.

 

-ENDS-

 

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:        ir@nanoporetech.com

Media:             media@nanoporetech.com

 

Teneo (communications adviser to the Company)

Tom Murray, Lisa Jarrett-Kerr

+44 (0) 20 7353 4200

OxfordNanoporeTechnologies@teneo.com

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.  Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.

For more information please visit: www.nanoporetech.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings